• 생명과학회지
• /
• 제9권1호
• /
• pp.58-62
• /
• 1999

몇가지 nucleoside 5'-monophosphate 유도체들과 지질 친화성을 증가시킨 nucleoside 5'-(3-pyridinyl carbonyl)monophosphate 유도체들을 합성한 후 Mouse leukemia P388, Murine mammary carcinoma FM3A, Human histiocytic lymphoma U937 세포들에 대해 시험관내에서 항암활성을 MTT를 이용한 방법으로 나타내었다. 그 결과 uridine 5'-(3-pyridinylcarbonyl) monophosphate(7)와 2',3'-didehydro-3'-deoxythymidine-5' -(3-pyridinylcarbonyl) monophoshate(8)의 inhibition이 uridine 5'-monophosphate(1)와 2',3'-didehydro-3'-deoxythymidine-5'-monophosphate(4) 보다 각각 증가하였다. 이는 nucleoside 5'-(3-pyridinylcarbonyl) monophosphate 유도체들이 임상적 한계를 극복할 수 있는 가능성을 보인 것이다.

• 생명과학회지
• /
• 제9권1호
• /
• pp.63-68
• /
• 1999

5-halogen substituted uridine, amino acid, peptide 및 penicillin G의 5'-amino -5' -deoxyuridine con-jugates, 5'-monophosphate uridine 유도체, 5'-monophosphate uridine -fat쇼 acid 유도체와 같은 nu-cleoside 화합물들을 화학적으로 합성한 후 이들의 항진균, 항균 및 항암 활성을 측정하였다. 5-Bromo-2',3'-O-isopropylideneuridine(6)은 Trichophyton rubrum의 성장을 억제하였다(MIC: $0.2{\mu}$g/ml). 5'-Amino-5' -deoxyuridine -penicillin G(19), 5'-amino-5'-deoxyuridine-cyclo(Phe -Asp)(20), 5-iodo-5'-amino -5' -deoxyuridine-penicillin G(22)는 항균적이었고(S. aureus에 대해 MIC가 $6.25{\mu}$g/ml) 뒤의 두 nucleoside 화합물은 항암 작용이 가장 강한 유도체이었다(L5178Y murine lymphoma cell에 대한 $IC_{50}$이 $6.5{\mu}$g/ml).

• 미생물학회지
• /
• 제29권6호
• /
• pp.353-360
• /
• 1991

5-substituted uridine(I,Br,Cl), 5'-amino-5'-deoxyuridine conjugates of amino acid, peptide and penicillin G, 5'-monophosphate uridine derivatives and 5'-monophosphate-fatty acid detrivatives were chemically synthesized. Their biological activities were determined as MIC and IC/sub 50/ unit against various pathogenic microorganisms in vitro. 5'-amino-5'-deoxyuridine-cyclo(Phe-Asp)(23), 5-iodo-5'-amino-deoxyuridine-penicillin G(26) were the most efficient; their IC/sub 50/ against L5178Y murine lymphoma cell was 6.5 h/ml, MIC against S. aureus (+) and E. coli (-) was 6.25 g/ml. MIC of 5-bromo-2', 3'-O-isopropylideneuridine(6) against Trichophyton rubrum was 0.2 g/ml. And 5'-monophosphate derivatives are more active than simple uridine derivatives, suggesting other modified nucleoside 5'-phosphate may be worthwhile examing further as a new prodrugs.

• 한국미생물·생명공학회지
• /
• 제18권5호
• /
• pp.471-475
• /
• 1990

내열성 Thermus caldopilus로부터 정제된 내열성의 adenylate kinase는 nucleoside monophosphate에 대해 nucleotide triphosphate보다 높은 기질 특이성을 보여 주었다. $P',P^5$-di(adenosine-5')pentaphosphate는 여러 기질에 있어 Thermus의 adenylate kinase에 대해 경쟁적 저해제로서 작용하였다. $Mg^{2+}$ 이외 여러 가지 2가 양이온은 $Ca^{2+}, Mg^{2+}, Ba^{2+}, Fe^{2+}$ 순위로 효소활성에 필요하였으며, 효소활성은 p-chloromucuribenzoic acid와 같은 sulfurhydryl 시약에 저해되지 않았으며, 식염이나 phosphenolpyruvate을 반응액 첨가하였을 때 활성화되었다.

• BMB Reports
• /
• 제35권4호
• /
• pp.403-408
• /
• 2002

A hypothetical 21.0 kDa protein (ORF O197) from Escherichia coli K-12 was cloned, purified, and characterized. The protein sequence of ORF O197(termed EcO197) shares a 33.5% identity with that of a novel NTPase from Methanococcus jannaschii. The EcO197 protein was purified using Ni-NTA affinity chromatography, protease digestion, and gel filtration column. It hydrolyzed nucleoside triphosphates with an O6 atom-containing purine base to nucleoside monophosphate and pyrophosphate. The EcO197 protein had a strong preference for deoxyinosine triphosphate (dITP) and xanthosine triphosphate (XTP), while it had little activity in the standard nucleoside triphosphates (dATP, dCTP, dGTP, and dTTP). These aberrant nucleotides can be produced by oxidative deamination from purine nucleotides in cells; they are potentially mutagenic. The mutation protection mechanisms are caused by the incorporation into DNA of unwelcome nucleotides that are formed spontaneously. The EcO197 protein may function to eliminate specifically damaged purine nucleotide that contains the 6-keto group. This protein appears to be the first eubacterial dITP-and XTP-hydrolyzing enzyme that has been identified.

• 한국미생물·생명공학회지
• /
• 제44권1호
• /
• pp.55-61
• /
• 2016

본 연구에서는 $BH_4$를 대체할 수 있는 유용물질인 세피아프테린의 생산성 증대를 위하여 GTP 생합성 경로의 유전자들을 동시에 발현할 수 있는 재조합 대장균을 제작하였다. 세피아프테린을 생산할 수 있는 재조합 대장균에서 gmk, ndk 및 guaA-guaB 유전자를 동시에 발현함으로써 세포 내 GTP의 농도가 대조구에 비해 약 200% 이상 증가하였고 $126.1{\pm}9.3mg/l$의 세피아프테린이 생산되었는데 이 결과는 대조구보다 세피아프테린의 생산량이 약 43% 증가된 것이다. GTP 생합성에 관여하는 개별 유전자의 단독 발현 또는 두 가지 유전자의 동시 발현은 세포 내 GTP 농도 향상 큰 영향을 미치지 못했지만 네 가지 유전자 모두를 동시에 발현하는 경우는 세포 내 GTP 농도를 유의적으로 증가시킨다는 것이 확인되었다. 결론적으로 세포 내 GTP 생합성에 관여하는 guaA-guaB, gmk 및 ndk 유전자를 동시에 발현함으로써 재조합 대장균에서 세피아프테린의 생산성 증가를 달성하였다.

• IMMUNE NETWORK
• /
• 제7권1호
• /
• pp.31-38
• /
• 2007

Background: Mizoribine (MZR) is an imidazole nucleoside isolated from Eupenicillium brefeldianum. MZR is currendy in clinical use for patients who have undergone renal transplantation. Therapeutic efficacy of MZR has also been demonstrated in rheumatoid arthritis and lupus nephritis. MZR has been shown to inhibit the proliferation or lymphocytes by interfering with inosine monophosphate dehydrogenase. Since the exact mechanism by which MZR benefits rheumatoid arthritis (RA) is not clear, we investigated the ability of MZR to direct its immunosuppressive influences on other antigen presenting cells, such as macrophages. Methods: Mouse macrophage RAW264.7 cells were stimulated with lipopolysaccharide in the presence of MZR. To elucidate the mechanism of the therapeutic efficacy in chronic inflammatory diseases, we examined the effects of MZR on the production of pro-inflammatory cytokines, nitric oxide (NO) and prostaglandin $E_2\;(PGE_2)$ in macrophages. Results: MZR dose-dependendy decreased the production of nitric oxide and pro- inflammatory cytokines such as tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$), interleukins $1{\beta}$ (IL-${\beta}$ and IL-6 $PGE_2$. Examination of gene expression levels showed that the anti-inflammatory effect correlated with the down-regulation of inducible nitiric oxide synthase expression, cycloxygenase-2 expression and TNF-${\alpha}$ gene expression. Conclusion: In this work, we resulted whether MZR $(1.25{\sim}10{\mu}g/ml)$ inhibited macrophage activation by inhibiting secretion of pro-inflammatory cytokines, NO and $PGE_2$. These findings provide an explanation for the therapeutic efficacy of MZR in chronic inflammation-associated diseases.

• 대한핵의학회지
• /
• 제38권2호
• /
• pp.198-204
• /
• 2004

Tumor cell proliferation is considered to be a useful prognostic indicator of tumor aggressiveness and tumor response to therapy but in vitro measurement of individual proliferation is complex and tedious work. PET imaging provides a noninvasive approach to measure tumor growth rate in situ. Early approaches have used $^{18}F$-FDG or methionine to monitor proliferation status. These 2 tracers detect changes in glucose and amino acid metabolism, respectively, and therefore provide only an indirect measure of proliferation status. More recent studies have focused on DNA synthesis itself as a marker of cell proliferation. Cell lines and tissues with a high proliferation rate require high rates of DNA synthesis. $[^{11}C]Thymidine$ was the first radiotracer for noninvasive imaging of tumor proliferation. The short half-life of $^{11}C$ and rapid metabolism of $[^{11}C]Thymidine$ in vivo make the radiotracer less suitable for routing use. Halogenated thymidine analogs such as 5-iodo-2-deoxyuridine (IUdR) can be successfully used as cell proliferation markers for in vitro studies because these compounds are rapidly incorporated into newly synthesized DNA. IUdR has been evaluated as a potential in vivo tracer in nuclear medicing but the image qualify and the calculation of proliferation rates are impaired by its rapid in vivo degradation. Hence, the thymidine analog $3'-deoxy-3'-^{18}F-fluorothymidine$ (FLT) was recently introduced as a stable proliferation marker with a suitable nuclide half-life and stable in vivo. $[^{18}F]FLT$ is phosphorylated to 3-fluorothymidine monophosphate by thymidine kinase 1 and reflects thymidine kinase 1 activity in proliferating cell. $[^{18}F]FLT$ PET is feasible in clincal use and well correlates with cellular proliferation. Choline is a precursor for the biosynthesis of phospholipids (in particular, phosphatidylcholine), which is the essential component of all eukaryotic cell membranes and $[^{11}C]choline$, which is a new marker for cellular proliferation.

• 한국어류학회지
• /
• 제23권1호
• /
• pp.1-9
• /
• 2011

ACP (annealing control primer)를 사용하여 DDRT (differential display reverse transcription)-PCR 방법으로 볼락의 성장단계에 따라 발현량 차이를 나타내는 DEG (differentially expressed gene)를 확보하였다. ACP 120개를 분석하여 18개월령 근육조직에서보다 6개월령 근육조직에서 발현량이 많은 DEG 16개와 6개월령 근육조직에서보다 18개월령 근육조직에서 발현량이 더 많은 DEG22개의 염기서열을 분석하였다. DEG 염기서열을 BLAST 검색한 결과, parvalbumin (PVALB) 등 18개의 유전자(PVALB, NDKB, TPM, TnI, GAPDH, CKM2, factor 2 SERF2, AMPD, TRICA, ARHGAP15, ESD, hsp70, COL1A2, GST, Midllip1, MYL1, SERCA1B, FTH1)와 69~95%의 상동성을 나타냈다. Real time PCR 분석법으로 6개월령 근육조직에서 발현량이 많은 DEG14와 PVALB 유전자의 성장단계별 발현양상을 조사한 결과, 볼락이 성장함에 따라 발현량이 감소하였으며, 특히 PVALB 유전자는 6개월령 이후에는 발현량이 극히 적었다. 6개월령 근육조직에서보다 18 개월령 근육조직에서 발현량에서 많았던 CKM2 유전자는 성장함에 따라 발현량이 계속 증가하였고, 4세 이후에는 발현량이 감소하였다. DEG의 조직특이적 발현양상을 분석한 결과, DEG14는 근육, 간, 신장, 및 비장조직에서 발현되었으며, PVALB 유전자는 근육과 신장조직에서 발현되었고, 간과 비장조직에서는 발현되지 않았다. CKM2 유전자는 근육, 신장 및 비장조직에서 발현되었고, 간 조직에서는 발현되지 않았다. PVALB 유전자의 mRNA 크기는 659 bp 이며, 110개의 아미노산으로 구성되어 있다. Parvalbumin과 CKM2 유전자는 성장속도가 빠른 어류 선발에 이용할 수 있는 분자마커 개발에 활용하고자한다.